<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>Zibb.com: Celgene Corporation (Web)</title><link>http://www.zibb.com/all/theme/cq/Celgene+Corporation</link><atom:link rel="self" type="application/rss+xml" href="http://www.zibb.com/all/theme/cq/Celgene+Corporation" /><description>
					Zibb. The Global business search engine.
				</description><language>
					en-US
				</language><webMaster>search@zibb.com (RB Search)</webMaster><copyright>Copyright (c) 2007 Reed Business Information. All rights reserved.</copyright><pubDate>Wed, 04 Jun 2008 12:14:16 GMT</pubDate><lastBuildDate>Wed, 04 Jun 2008 12:14:16 GMT</lastBuildDate><ttl>60</ttl><image><title>Zibb.com: Celgene Corporation (Web)
          </title><width>88</width><height>31</height><link>http://www.zibb.com/all/theme/cq/Celgene+Corporation</link><url>
						http://www.zibb.com/images/en/g_zibb_logo_beta.gif
					</url></image><item><title>[video] 3 Stocks I Saw on TV (at TheStreet.com)</title><link>http://www.thestreet.com/_yahoo/video/strategysession/10419675.html?cm_ven=YAHOOV&amp;amp;cm_cat=FREE&amp;amp;cm_ite=NA</link><description>Dan Fitzpatrick examines three stocks viewed on Fast Money. Today's stocks include Wachovia, Celgene and General Motors.</description><guid>http://www.thestreet.com/_yahoo/video/strategysession/10419675.html?cm_ven=YAHOOV&amp;amp;cm_cat=FREE&amp;amp;cm_ite=NA</guid><category domain="http://www.zibb.com">Celgene Corporation</category><pubDate>Wed, 04 Jun 2008 12:14:16 GMT</pubDate><source url="http://www.thestreet.com" /></item><item><title>Apria - resources - News</title><link>http://www.apria.com/resources/1,2725,494-867778-3,00.html</link><description>Jan 01, 2009 (Zacks Investment Research via COMTEX) -- Celgene Corp. (CELG) is a fully integrated biotechnology company focused on discovery, development and commercialization of drugs in the area of cancer and immune/inflammatory diseases.</description><guid>http://www.apria.com/resources/1,2725,494-867778-3,00.html</guid><category domain="http://www.zibb.com">Celgene Corporation</category><pubDate /><source url="http://www.apria.com" /></item><item><title>GPC-Biotech</title><link>http://www.gpc-biotech.com/en/anticancer_programs/satraplatin/clinical_trials/</link><description>Satraplatin, an investigational drug, is a member of the platinum family of compounds. Platinum-based drugs are a critical part of modern chemotherapy treatments and are used to treat a wide variety of cancers. All platinum drugs currently on the market require intravenous administration.</description><guid>http://www.gpc-biotech.com/en/anticancer_programs/satraplatin/clinical_trials/</guid><category domain="http://www.zibb.com">Celgene Corporation</category><pubDate /><source url="http://www.gpc-biotech.com" /></item><item><title>Free Historical Stock Price Data on Celgene Corp , Historical Sto...
      </title><link>http://www.price-data.com/celg.cfm</link><description>Receive a complete Daily History of this Stock You can receive a complete daily file of this issue since 1970 or stock inception. We will email you the file in ASCII format within a few hours or ordering.</description><guid>http://www.price-data.com/celg.cfm</guid><category domain="http://www.zibb.com">Celgene Corporation</category><pubDate /><source url="http://www.price-data.com" /></item><item><title>Celgene Cancer Company Profile (market briefing)</title><link>http://www.biz-lib.com/ZEB67189.html</link><description>Over 135 reports on companies developing anti-cancer drugs from the largest blue-chip multinational to smaller specialist organisations - and all phases of development from research to launched products.</description><guid>http://www.biz-lib.com/ZEB67189.html</guid><category domain="http://www.zibb.com">Celgene Corporation</category><pubDate /><source url="http://www.biz-lib.com" /></item><item><title>Manage Celgene Investigation Function: Directly supervise the QA ...
      </title><link>http://www.artacseel.com/id74_m.htm</link><description>Manage Celgene Investigation Function: Directly supervise the QA Investigation Coordinator and other individuals responsible for the review, approval, tracking and trending of laboratory investigations, deviations and associated CAPAs at Celgene. Oversees the Investigation function.</description><guid>http://www.artacseel.com/id74_m.htm</guid><category domain="http://www.zibb.com">Celgene Corporation</category><pubDate /><source url="http://www.artacseel.com" /></item><item><title>Quality Alternative : Clients Served</title><link>http://www.qualityalternatives.com/clients_served.html</link><description>Design of 12,000 sq.ft R&amp;D laboratories, administrative support, warehouse area, and mechanical equipment room.</description><guid>http://www.qualityalternatives.com/clients_served.html</guid><category domain="http://www.zibb.com">Celgene Corporation</category><pubDate /><source url="http://www.qualityalternatives.com" /></item><item><title>Imagination - Zoomedia, Inc.</title><link>http://www.zoomedia.com/imagination</link><description>We constantly challenge our thinking, question convention, and find the best way forward for each and every client. Clear thinking coupled with deep understanding results in powerful solutions that open up new possibilities.</description><guid>http://www.zoomedia.com/imagination</guid><category domain="http://www.zibb.com">Celgene Corporation</category><pubDate /><source url="http://www.zoomedia.com" /></item><item><title>CELGENE CP Share Price Stock, Quote | CELG | US1510201049 | Yahoo...
      </title><link>http://uk.finance.yahoo.com/q?s=CELG</link><description>Copyright 2007 (c) Yahoo! UK Ltd. All rights reserved. Questions | Disclaimer | Quotes Information Quotes delayed except where indicated otherwise. Delay time is 20 mins for London stock exchange. See also delay times for other exchanges.</description><guid>http://uk.finance.yahoo.com/q?s=CELG</guid><category domain="http://www.zibb.com">Celgene Corporation</category><pubDate /><source url="http://uk.finance.yahoo.com" /></item><item><title>Celgene - Analyst News | newratings.com</title><link>http://www.newratings.com/headlines/Celgene_US1510201049.html</link><description>Copyright © 2002 - 2008 newratings.com GmbH | Legal | Licensing Quote data provided by IS.eFinance Solutions (powered by IS.Teledata AG) using StandardPoor's ComStock Inc. and others. Delay times are 15 mins for European exchanges and NASDAQ, 20 mins for NYSE and AMEX.</description><guid>http://www.newratings.com/headlines/Celgene_US1510201049.html</guid><category domain="http://www.zibb.com">Celgene Corporation</category><pubDate /><source url="http://www.newratings.com" /></item><item><title>Array BioPharma is creating the next generation of orally active ...
      </title><link>http://www.arraybiopharma.com/Collaboration/Collaborators.asp</link><description>We have research collaborations with leading pharmaceutical and biotechnology companies that include the design, creation and optimization of drug candidates across a broad range of therapeutic areas.</description><guid>http://www.arraybiopharma.com/Collaboration/Collaborators.asp</guid><category domain="http://www.zibb.com">Celgene Corporation</category><pubDate /><source url="http://www.arraybiopharma.com" /></item><item><title>IDT - News</title><link>http://www.idtaus.com.au/asx/500607.html</link><description>Institute of Drug Technology Australia Ltd (IDT) has been granted approval by the US Food and Drug Administration to supply commercial quantities of THALOMID ® (thalidomide) to its client, Celgene Corporation, a U.S. based global biopharmaceutical company.</description><guid>http://www.idtaus.com.au/asx/500607.html</guid><category domain="http://www.zibb.com">Celgene Corporation</category><pubDate /><source url="http://www.idtaus.com.au" /></item><item><title>RT Magazine - The Journal for Respiratory Care Practitioners</title><link>http://www.rtmagazine.com/prnews.php?p=141</link><description>The updated study data reported that after seven treatment cycles with R-MP all patients showed a response with no further disease progressions observed, and event-free survival (EFS) (p&lt;0.001) after 9.6 month of follow-up.</description><guid>http://www.rtmagazine.com/prnews.php?p=141</guid><category domain="http://www.zibb.com">Celgene Corporation</category><pubDate /><source url="http://www.rtmagazine.com" /></item><item><title>Revlimid New Drug Application</title><link>http://www.drugs.com/nda/revlimid_050607.html</link><description>Drugs.com - prescription drug and over the counter medicine information available on over 24,000 approved medications and pharmaceuticals, including side effects and drug interactions.</description><guid>http://www.drugs.com/nda/revlimid_050607.html</guid><category domain="http://www.zibb.com">Celgene Corporation</category><pubDate /><source url="http://www.drugs.com" /></item><item><title>North Jersey Media Group providing local news, sports &amp; classifie...
      </title><link>http://www.northjersey.com/page.php?qstr=eXJpcnk3ZjczN2Y3dnFlZUVFeXkyOSZmZ2JlbDdmN3ZxZWVFRXl5NzA2Mzk3OSZ5cmlyeTdmNzE3Zjd2cWVlRUV5eTE=</link><description>Celgene Corp. has sued to prevent Barr Pharmaceuticals Corp. from selling a generic version of the leprosy and blood-cancer treatment Thalomid, Celgene's biggest-selling drug. Barr is seeking U.S. Food and Drug Administration approval to sell a generic version of the drug.</description><guid>http://www.northjersey.com/page.php?qstr=eXJpcnk3ZjczN2Y3dnFlZUVFeXkyOSZmZ2JlbDdmN3ZxZWVFRXl5NzA2Mzk3OSZ5cmlyeTdmNzE3Zjd2cWVlRUV5eTE=</guid><category domain="http://www.zibb.com">Celgene Corporation</category><pubDate /><source url="http://www.northjersey.com" /></item><item><title>Breast Cancer Clinical Trials Resource Guide | 2008</title><link>http://www.breastcancerupdate.com/SABCSTrials/faculty.asp</link><description>Research To Practice (RTP) is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess potential conflicts of interest with faculty, planners and managers of CME activities.</description><guid>http://www.breastcancerupdate.com/SABCSTrials/faculty.asp</guid><category domain="http://www.zibb.com">Celgene Corporation</category><pubDate /><source url="http://www.breastcancerupdate.com" /></item><item><title>EvaluatePharma - Celgene Sample Information</title><link>http://www.evaluatepharma.com/CoInfo/CoInfo-CELG.htm</link><description>EvaluatePharma provides historic and forecast sales from 1986 to 2010 for worldwide and US Rx (prescription drugs) and OTC drugs. EvaluatePharma analysts continuously update company models from SEC filings, annual reports, investor/analyst presentations, company press releases, FDA and USPTO.</description><guid>http://www.evaluatepharma.com/CoInfo/CoInfo-CELG.htm</guid><category domain="http://www.zibb.com">Celgene Corporation</category><pubDate /><source url="http://www.evaluatepharma.com" /></item><item><title>Celgene Goes Live with Pilgrim Software’s SmartAudit</title><link>http://www.pilgrimsoftware.com/press/celgene-goes-live-audit.shtml</link><description>Tampa, FL – January 26, 2006 – Pilgrim Software, Inc., the leading provider of Enterprise Quality and Compliance Management Solutions, announces that Celgene has gone live with SmartAudit to enhance and facilitate management of its auditing processes.</description><guid>http://www.pilgrimsoftware.com/press/celgene-goes-live-audit.shtml</guid><category domain="http://www.zibb.com">Celgene Corporation</category><pubDate /><source url="http://www.pilgrimsoftware.com" /></item><item><title>Biopharmaceuticals - Celgene Corporation to Present at Credit Sui...
      </title><link>http://www.newsrx.com/health-articles/782191.html</link><description>Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of novel therapies for the treatment of cancer A term for diseases in which abnormal cells divide without control.</description><guid>http://www.newsrx.com/health-articles/782191.html</guid><category domain="http://www.zibb.com">Celgene Corporation</category><pubDate /><source url="http://www.newsrx.com" /></item><item><title>Celgene Drug Discovery &amp; Development—Ligase Modulators</title><link>http://www.celgene.com/research/ligase-modulators.aspx</link><description>Ubiquitin ligases are important molecules that control key cellular functions by maintaining appropriate levels and types of proteins within cells. Ubiquitin-mediated protein modulation regulates a broad range of cellular processes including cell proliferation, differentiation and survival/death.</description><guid>http://www.celgene.com/research/ligase-modulators.aspx</guid><category domain="http://www.zibb.com">Celgene Corporation</category><pubDate /><source url="http://www.celgene.com" /></item><item><title>Celgene Corporation - Company Profile - Computer Business Review</title><link>http://www.computerbusinessreview.com/companyprofile.asp?guid=4FC7F325-ACDE-41FC-9BEC-382FB582751B</link><description>** NEW FEATURE ** Sign-up for NewsAlerts on Celgene Corporation so that whenever news breaks on this company you are amongst the first to know. Click here...</description><guid>http://www.computerbusinessreview.com/companyprofile.asp?guid=4FC7F325-ACDE-41FC-9BEC-382FB582751B</guid><category domain="http://www.zibb.com">Celgene Corporation</category><pubDate /><source url="http://www.computerbusinessreview.com" /></item><item><title>Stock of the Day: Celgene Corporation (CELG)</title><link>http://www.investorguide.com/stock-archives.cgi?date=030705</link><description>* We need your e-mail address because this newsletter will be sent to your e-mail box. InvestorGuide does not sell, rent, or give away your personal information. Please read our privacy policy.</description><guid>http://www.investorguide.com/stock-archives.cgi?date=030705</guid><category domain="http://www.zibb.com">Celgene Corporation</category><pubDate /><source url="http://www.investorguide.com" /></item><item><title>Former IBM Chief Dies At 85 - Hardware - IT Channel News by CRN a...
      </title><link>http://www.crn.com/hardware/175801938</link><description>The news was first disclosed in a public filing Wednesday by Lexmark, a company spun off from IBM in 1991. Cary had been on the board of Lexington, Ky.-based printer company.</description><guid>http://www.crn.com/hardware/175801938</guid><category domain="http://www.zibb.com">Celgene Corporation</category><pubDate /><source url="http://www.crn.com" /></item><item><title>James Love: $6,195 a Month for Celgene's Cancer Drug: Is There a ...
      </title><link>http://www.huffingtonpost.com/james-love/6195-a-month-for-celgen_b_24293.html</link><description>Geeta Anand's July 1 report in the WSJ regarding Celgene's $74 thousand dollar per year drug Revlimid is just the latest to ask the question -- how high can drug prices go?</description><guid>http://www.huffingtonpost.com/james-love/6195-a-month-for-celgen_b_24293.html</guid><category domain="http://www.zibb.com">Celgene Corporation</category><pubDate /><source url="http://www.huffingtonpost.com" /></item><item><title>CELG - Celgene Corporation Stock Quotes, News, Stock Charts, Repo...
      </title><link>http://www.quotelinks.com/companies/celg.html</link><description>Stock quotes, news and charts for Celgene Corporation Quotes Simple Charts Stock News MSN Investor Thomson Investors Short Interest Yahoo Finance CBS Marketwatch BigCharts StockCharts.com Yahoo Lycos Investing Quicken Yahoo News Quote.com (Lycos) CNET news ZDNet Business Week Stock earnings,</description><guid>http://www.quotelinks.com/companies/celg.html</guid><category domain="http://www.zibb.com">Celgene Corporation</category><pubDate /><source url="http://www.quotelinks.com" /></item></channel></rss>